AzTrials
AzTrials

All Emergency Department Visits Meeting Eligibility CriteriaNCT07804407

Prospective Evaluation of AI Generated History of Present Illness Drafts in the Emergency Department

An observational study of All Emergency Department Visits Meeting Eligibility Criteria, run by Yonsei University at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This single-center prospective observational study evaluates whether an on-premise, large language model-based tool (EDnote) that generates a draft history of present illness (HPI) from real-time transcription of the patient-physician encounter produces documentation of higher quality than conventional… Read more about this study

Who is it for?
Ages 19 years and older
What is being tested?
EDnote HPI (AI-generated HPI draft) and Conventional physician HPI
How many people
100 participants
Where
1 siteSouth Korea
Study dates
1 Sep 2026to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients presenting to the emergency department of a single tertiary teaching hospital in Korea.

Who may be able to join

  • Age ≥19 years; presenting to the emergency department; initial encounter documented with EDnote; verbal consent to study participation.

Who cannot join

  • Cardiac arrest; limited ability of both patient and guardian to communicate verbally; refusal of participation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

South Korea1 site, 1 recruiting
  • Yonsei University Severance Hospital

    Seoul, Seoul City, 03722

    Stephen GW LEE, 82-2-2228-2678, leestephengyungwon@yuhs.ac

    Recruiting

Other trials in South Korea

About this study

Official title: Prospective Evaluation of Artificial Intelligence-generated History of Present Illness Drafts in the Emergency Department

This single-center prospective observational study evaluates whether an on-premise, large language model-based tool (EDnote) that generates a draft history of present illness (HPI) from real-time transcription of the patient-physician encounter produces documentation of higher quality than conventional physician-written HPI in the emergency department. The treating physician writes the conventional HPI blinded to the AI draft. Unedited AI-generated HPI drafts and conventional HPI are compared through blinded review by independent emergency physicians.

Being tested
EDnote HPI (AI-generated HPI draft), Conventional physician HPI
Keywords
emergency department, ai scribe, ambient scribe, history of present illness
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EDnote HPI (AI-generated HPI draft)Other

    On-premise large language model-based tool that transcribes the patient-physician encounter in real time and generates an unedited HPI draft. The treating physician is blinded to the AI HPI draft.

  • Conventional physician HPIOther

    HPI written by the treating emergency physician according to usual practice, blinded to the EDnote-generated HPI draft.

Study groups in NCT07804407
Study groupRoleWhat they receive
ED patients with EDnote-assisted initial encounterAdult emergency department patients whose initial encounter was recorded by EDnote. While the treating physician conducts usual care and writes the conventional HPI, EDnote generates an AI HPI draft in the background; the physician remains blinded to the draft. Both HPIs are evaluated by independent raters blinded to document source.
Receives: Other: EDnote HPI (AI-generated HPI draft); Other: Conventional physician HPI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Encounter-level clinical fact capture rate

    Measured: At blinded review, within 6 months after each index ED visit

Secondary outcomes (3)
  1. Modified PDQI-9 score

    Modified Physician Documentation Quality Instrument-9 (Modified PDQI-9) score. The modified instrument consists of 10 items, each rated from 1 to 5, yielding a total score ranging from 10 to 50. Higher scores indicate better documentation quality.

    Measured: At blinded review, within 6 months after each index ED visit

  2. AI HPI draft generation time

    Measured: At index ED visit

  3. Rater identification of document authorship (AI vs. physician-written)

    Measured: At blinded review, within 6 months after each index ED visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07804407
Sponsor's protocol ID
4-2026-0708
Other IDs
C-2026-0010
Status last verified
Sep 2026
First submitted
1 Sep 2026
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to concerns regarding patient privacy and personal information protection.

Questions about this trial

What is this clinical trial studying?

An observational study of All Emergency Department Visits Meeting Eligibility Criteria, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stephen GW LEE (82-2-2228-2678, leestephengyungwon@yuhs.ac), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Encounter-level clinical fact capture rate (time frame: At blinded review, within 6 months after each index ED visit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in